
Q&A with TransCelerate’s new CEO Janice Chang: Bringing the trial infrastructure to patients
TransCelerate Biopharma is unique in the nonprofit space because it brings together more than 20 top pharma competitors and allows them to collaborate, rather than compete, on common R&D pain points.
Helping to build this collaborative environment is TransCelerate’s new CEO Janice Chang, who moved into her new role in January after serving as COO for more than a decade.
Chang sat down with Endpoints News for an in-person interview at the DIA conference in Boston on Wednesday. Below is a lightly edited version of that conversation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.